Back to News
Market Impact: 0.1

Commit To Buy Hologic At $62.50, Earn 7% Annualized Using Options

HOLXKEYPLXSNDAQ
Futures & OptionsDerivatives & VolatilityCompany FundamentalsMarket Technicals & Flows
Commit To Buy Hologic At $62.50, Earn 7% Annualized Using Options

Selling a December $62.50 strike put option on Hologic Inc (HOLX) offers a 7% annualized rate of return from the collected premium. This strategy entails potential share acquisition at a $61.10 cost basis if HOLX shares decline 7% or more from their current $67.26 price. Evaluating this risk/reward is advised using HOLX's 28% trailing twelve-month volatility and fundamental analysis.

Analysis

The article presents a specific income-generating options strategy on Hologic Inc (HOLX), involving the sale of a December put option with a $62.50 strike price. This trade generates an immediate premium of $1.40 per share, which translates to a 7% annualized rate of return. The strategy's primary risk is the obligation to purchase HOLX shares at $62.50 if the stock price declines approximately 7% from its current level of $67.26 by expiration. This would establish an effective cost basis of $61.10 per share. A key data point for risk assessment is the stock's trailing twelve-month volatility of 28%, which investors must weigh against the offered yield. The analysis suggests that this trade is not designed for capturing upside potential in HOLX stock; rather, its attractiveness depends on an investor's view of the risk-reward profile, particularly whether the 7% annualized return is adequate compensation for the downside price risk and potential share assignment.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

HOLX0.00
KEY0.00
NDAQ0.00
PLXS0.00

Key Decisions for Investors

  • Investors with a neutral-to-bullish outlook on HOLX who are comfortable acquiring shares at an effective cost of $61.10 could execute this put-selling strategy to generate a 7% annualized income.
  • Given the stock's 28% trailing volatility, a careful assessment is required to determine if the premium provides sufficient compensation for the risk of being assigned the stock in a potential downturn.
  • This strategy is inappropriate for investors seeking direct capital appreciation, as the potential gain is capped at the collected premium unless the option is exercised, forgoing any upside if the stock price rises.